Shopping Cart 0
Cart Subtotal
AED 0

Vanda Pharmaceuticals Inc (VNDA) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376

Details

Vanda Pharmaceuticals Inc (VNDA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company's operations and business divisions.

- Corporate strategy - Analyst's summarization of the company's business strategy.

- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history - Progression of key events associated with the company.

- Major products and services - A list of major products, services and brands of the company.

- Key competitors - A list of key competitors to the company.

- Key employees - A list of the key executives of the company.

- Executive biographies - A brief summary of the executives' employment history.

- Key operational heads - A list of personnel heading key departments/functions.

- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities - A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Vanda Pharmaceuticals Inc (Vanda) is a specialty pharmaceutical company that develops and commercializes novel therapies for the treatment of central nervous system disorders. The company's products include Hetlioz, a melatonin receptor agonist for the treatment of non-24-hour sleep-wake disorder; and Fanapt, an atypical antipsychotic for the treatment of schizophrenia in adults. Its pipeline portfolio includes Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist for pruritus in atopic dermatitis; VQW-765, an alpha-7 nicotinic acetylcholine receptor for CNS disorders; and VTR-297 for oncology indications. Vanda is headquartered in Washington DC, the US.

Vanda Pharmaceuticals Inc Key Recent Developments

May 01,2019: Vanda Pharmaceuticals reports first quarter 2019 financial results

Apr 24,2019: Vanda Pharmaceuticals names Phaedra Chrousos to Board of Directors

Apr 03,2019: Hagens Berman reminds Vanda Pharmaceuticals investors of April 26, 2019 lead plaintiff deadline and encourages investors to contact the firm

Feb 13,2019: Vanda Pharmaceuticals reports fourth quarter 2018 and full year 2018 financial results

Feb 12,2019: Wolf Popper announces investigation on behalf of investors in Vanda Pharmaceuticals

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Vanda Pharmaceuticals Inc - Key Facts

Vanda Pharmaceuticals Inc - Key Employees

Vanda Pharmaceuticals Inc - Key Employee Biographies

Vanda Pharmaceuticals Inc - Major Products and Services

Vanda Pharmaceuticals Inc - History

Vanda Pharmaceuticals Inc - Company Statement

Vanda Pharmaceuticals Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 - Company Analysis

Company Overview

Vanda Pharmaceuticals Inc - Business Description

Product Category: Fanapt

Overview

Performance

Product Category: HETLIOZ

Overview

Performance

R&D Overview

Vanda Pharmaceuticals Inc - Corporate Strategy

Vanda Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

Vanda Pharmaceuticals Inc - Strengths

Vanda Pharmaceuticals Inc - Weaknesses

Vanda Pharmaceuticals Inc - Opportunities

Vanda Pharmaceuticals Inc - Threats

Vanda Pharmaceuticals Inc - Key Competitors

Section 3 - Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 - Company's Lifesciences Financial Deals and Alliances

Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Vanda Pharmaceuticals Inc, Recent Deals Summary

Section 5 - Company's Recent Developments

May 01, 2019: Vanda Pharmaceuticals reports first quarter 2019 financial results

Apr 24, 2019: Vanda Pharmaceuticals names Phaedra Chrousos to Board of Directors

Apr 03, 2019: Hagens Berman reminds Vanda Pharmaceuticals investors of April 26, 2019 lead plaintiff deadline and encourages investors to contact the firm

Feb 13, 2019: Vanda Pharmaceuticals reports fourth quarter 2018 and full year 2018 financial results

Feb 12, 2019: Wolf Popper announces investigation on behalf of investors in Vanda Pharmaceuticals

Feb 05, 2019: Vanda Pharmaceuticals takes a stand against unnecessary animal research

Nov 07, 2018: Vanda Pharmaceuticals announces third quarter 2018 financial results

Nov 01, 2018: Vanda receives FDA letter regarding corporate webpage

Aug 01, 2018: Vanda pharmaceuticals reports second quarter 2018 financial results

May 02, 2018: Vanda Pharmaceuticals Reports First Quarter 2018 Financial Results

Section 6 - Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Vanda Pharmaceuticals Inc, Performance Chart (2014 - 2018)

Vanda Pharmaceuticals Inc, Ratio Charts

Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Vanda Pharmaceuticals Inc, Key Facts

Vanda Pharmaceuticals Inc, Key Employees

Vanda Pharmaceuticals Inc, Key Employee Biographies

Vanda Pharmaceuticals Inc, Major Products and Services

Vanda Pharmaceuticals Inc, History

Vanda Pharmaceuticals Inc, Subsidiaries

Vanda Pharmaceuticals Inc, Key Competitors

Vanda Pharmaceuticals Inc, Ratios based on current share price

Vanda Pharmaceuticals Inc, Annual Ratios

Vanda Pharmaceuticals Inc, Annual Ratios (Cont...1)

Vanda Pharmaceuticals Inc, Interim Ratios

Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Vanda Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Vanda Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Teva Pharmaceutical Industries Ltd

Takeda Pharmaceutical Co Ltd

Sunovion Pharmaceuticals Inc

Sanofi

Pfizer Inc

Pernix Therapeutics Holdings Inc

Neurim Pharmaceuticals Ltd

Merck & Co Inc

Les Laboratoires Servier SAS

Allergan Plc

Company Profile

Company Profile Title

Vanda Pharmaceuticals Inc (VNDA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company's operations and business divisions.

- Corporate strategy - Analyst's summarization of the company's business strategy.

- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history - Progression of key events associated with the company.

- Major products and services - A list of major products, services and brands of the company.

- Key competitors - A list of key competitors to the company.

- Key employees - A list of the key executives of the company.

- Executive biographies - A brief summary of the executives' employment history.

- Key operational heads - A list of personnel heading key departments/functions.

- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities - A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Vanda Pharmaceuticals Inc (Vanda) is a specialty pharmaceutical company that develops and commercializes novel therapies for the treatment of central nervous system disorders. The company's products include Hetlioz, a melatonin receptor agonist for the treatment of non-24-hour sleep-wake disorder; and Fanapt, an atypical antipsychotic for the treatment of schizophrenia in adults. Its pipeline portfolio includes Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist for pruritus in atopic dermatitis; VQW-765, an alpha-7 nicotinic acetylcholine receptor for CNS disorders; and VTR-297 for oncology indications. Vanda is headquartered in Washington DC, the US.

Vanda Pharmaceuticals Inc Key Recent Developments

May 01,2019: Vanda Pharmaceuticals reports first quarter 2019 financial results

Apr 24,2019: Vanda Pharmaceuticals names Phaedra Chrousos to Board of Directors

Apr 03,2019: Hagens Berman reminds Vanda Pharmaceuticals investors of April 26, 2019 lead plaintiff deadline and encourages investors to contact the firm

Feb 13,2019: Vanda Pharmaceuticals reports fourth quarter 2018 and full year 2018 financial results

Feb 12,2019: Wolf Popper announces investigation on behalf of investors in Vanda Pharmaceuticals

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Vanda Pharmaceuticals Inc - Key Facts

Vanda Pharmaceuticals Inc - Key Employees

Vanda Pharmaceuticals Inc - Key Employee Biographies

Vanda Pharmaceuticals Inc - Major Products and Services

Vanda Pharmaceuticals Inc - History

Vanda Pharmaceuticals Inc - Company Statement

Vanda Pharmaceuticals Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 - Company Analysis

Company Overview

Vanda Pharmaceuticals Inc - Business Description

Product Category: Fanapt

Overview

Performance

Product Category: HETLIOZ

Overview

Performance

R&D Overview

Vanda Pharmaceuticals Inc - Corporate Strategy

Vanda Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

Vanda Pharmaceuticals Inc - Strengths

Vanda Pharmaceuticals Inc - Weaknesses

Vanda Pharmaceuticals Inc - Opportunities

Vanda Pharmaceuticals Inc - Threats

Vanda Pharmaceuticals Inc - Key Competitors

Section 3 - Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 - Company's Lifesciences Financial Deals and Alliances

Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Vanda Pharmaceuticals Inc, Recent Deals Summary

Section 5 - Company's Recent Developments

May 01, 2019: Vanda Pharmaceuticals reports first quarter 2019 financial results

Apr 24, 2019: Vanda Pharmaceuticals names Phaedra Chrousos to Board of Directors

Apr 03, 2019: Hagens Berman reminds Vanda Pharmaceuticals investors of April 26, 2019 lead plaintiff deadline and encourages investors to contact the firm

Feb 13, 2019: Vanda Pharmaceuticals reports fourth quarter 2018 and full year 2018 financial results

Feb 12, 2019: Wolf Popper announces investigation on behalf of investors in Vanda Pharmaceuticals

Feb 05, 2019: Vanda Pharmaceuticals takes a stand against unnecessary animal research

Nov 07, 2018: Vanda Pharmaceuticals announces third quarter 2018 financial results

Nov 01, 2018: Vanda receives FDA letter regarding corporate webpage

Aug 01, 2018: Vanda pharmaceuticals reports second quarter 2018 financial results

May 02, 2018: Vanda Pharmaceuticals Reports First Quarter 2018 Financial Results

Section 6 - Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Vanda Pharmaceuticals Inc, Performance Chart (2014 - 2018)

Vanda Pharmaceuticals Inc, Ratio Charts

Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Vanda Pharmaceuticals Inc, Key Facts

Vanda Pharmaceuticals Inc, Key Employees

Vanda Pharmaceuticals Inc, Key Employee Biographies

Vanda Pharmaceuticals Inc, Major Products and Services

Vanda Pharmaceuticals Inc, History

Vanda Pharmaceuticals Inc, Subsidiaries

Vanda Pharmaceuticals Inc, Key Competitors

Vanda Pharmaceuticals Inc, Ratios based on current share price

Vanda Pharmaceuticals Inc, Annual Ratios

Vanda Pharmaceuticals Inc, Annual Ratios (Cont...1)

Vanda Pharmaceuticals Inc, Interim Ratios

Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Vanda Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Vanda Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Teva Pharmaceutical Industries Ltd

Takeda Pharmaceutical Co Ltd

Sunovion Pharmaceuticals Inc

Sanofi

Pfizer Inc

Pernix Therapeutics Holdings Inc

Neurim Pharmaceuticals Ltd

Merck & Co Inc

Les Laboratoires Servier SAS

Allergan Plc